Tel Aviv University’s TTO has set up a business called Nemis Technologies in partnership with BioSynth to develop pathological bacteria detection technologies powered by chemiluminescence.

Indiana University Research and Technology Corp has been awarded Tech Transfer Unit of the Year by Global University Venturing

University of Birmingham has spun out Viatem to develop a treatment for rheumatoid arthritis.

Andrew Gaule discusses tech transfer and university incubation with Tal Badt, X-lab Tsinghua University, and Quentin Compton-Bishop, Warwick Ventures.

Based on research at Johns Hopkins University, Escient Pharmaceuticals is developing treatments for serious but unserved medical needs.

Vascugen has brought on-board more licences related to stem cell therapies that could restore blood vessels in tissues where the blood flow has been restricted.

Platinum Informatics has received two grants for its big data analytics software, which could find utility in segments including pharmaceuticals and healthcare.

Harvard-linked immunotherapy developer T-Scan Therapeutics will be helmed by serial biotech entrepreneur Christoph Westphal, who has previously achieved multiple exits.